| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $373K | +4.2% |
| Cost of Revenue | $261K | +33.4% |
| Gross Profit | $112K | -31.0% |
| R&D Expense | $11.3M | +75.5% |
| SG&A Expense | $12.9M | +76.2% |
| Operating Income | -$25.9M | +4.7% |
| Pre-tax Income | -$68.5M | -153.7% |
| Net Income | -$68.5M | -130.5% |
| EPS (Basic) | -$0.73 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78.9M | +3733.6% |
| Accounts Receivable | $27K | -58.5% |
| Inventory | $18K | -75.2% |
| Current Assets | $79.2M | +2387.7% |
| Total Assets | $153.6M | +95.0% |
| Current Liabilities | $4.6M | -1.3% |
| Total Liabilities | $46.3M | +747.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.2M | +18.7% |
| Capital Expenditures | $6.0M | +185.0% |
| Investing Cash Flow | -$6.0M | -130.6% |
| Financing Cash Flow | $99.1M | +413.4% |
| Free Cash Flow | -$22.2M | -0.9% |
| -92.1% |
| EPS (Diluted) | -$0.73 | -135.5% |
| Stockholders' Equity |
| $107.3M |
| +46.4% |